middle.news

4DMedical Launches CLEAR Program to Target $3B US Pulmonary Embolism Market

8:30am on Tuesday 2nd of June, 2026 AEST Healthcare
Read Story

4DMedical Launches CLEAR Program to Target $3B US Pulmonary Embolism Market

8:30am on Tuesday 2nd of June, 2026 AEST
Key Points
  • CLEAR program to fast-track CT:VQ™ in acute pulmonary embolism
  • Clinical study compares CT:VQ™ directly with CTPA standard
  • Partnership with Mass General Brigham anchors research
  • Targets US$3 billion obtainable market in the US
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about 4Dmedical (ASX:4DX)
OPEN ARTICLE